Bolu Abant İzzet Baysal University
Bolu, 14030, Turkey (Türkiye)
NCT Number: NCT06554379
Anamnesis was taken from 108 patients aged 18-33 who applied to the clinic and met the inclusion criteria. Photographs of the patients' smiles were taken without any measurement. Plaque , gingival index , bleeding on probing, pocket depth measurements, clinical attachment, and gingival recession levels were measured, respectively. Patients were divided into two groups: peri-implant health and gingivitis. Gingival thickness and keratinized gingival width were also measured. In addition, the smile aesthetic index, style, type, and stage were also determined using the smile classification system. Gingival visibility was measured in mm from the photographs taken.
Looking for future studies?
Notify Me18 year–33 year
All sexes
Observational
Bolu, 14030, Turkey (Türkiye)
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The presence or absence of periodontal disease in the gingiva was determined.
Time frame: Baseline
Keratinized gingival thickness refers to the vertical measurement of the gingival tissue that extends from the free gingival margin to the mucogingival junction, characterized by a keratinized epithelial layer which provides enhanced protection and stability to the underlying periodontal structures.
Time frame: Baseline
Keratinized gingival width refers to the horizontal dimension of the gingival tissue that is keratinized, measured from the free gingival margin to the mucogingival junction.
Time frame: Baseline
The gingival displays were measured by measuring the distances from the zenith points to the vermilion border
Time frame: Baseline
. The aforementioned factors were assigned a number (0 or 1) depending on their presence or absence, and the total of the assigned numbers indicates the subject's SEI (which ranges from 0 for very poor to 10 for very good)
Time frame: Baseline
Smile style (Commissura smile, sharp smile, and complex smile), stage (Stage I, Stage II, Stage III, and Stage IV), and type (Type 1, Type 2, Type 3, and Type 4) were analyzed with the smile classification system
Time frame: Baseline
The visible end of the periodontal probe in the sulcus represents a thin gingival phenotype, while the invisible end corresponds to a thick gingival phenotype
Time frame: Baseline
The plaque index assesses the amount of dental plaque visible on the vestibular and lingual surfaces of all teeth
Time frame: Baseline
This measurement is based on the presence or absence of bleeding on gentle probing
Time frame: Baseline
Bleeding, leading sign of inflammation inside the connective tissue, is a critical factor for pocket depth measurements, and with other variable factors prevents making reproducible measurements.
Time frame: Baseline
A pathologically deepened gingival sulcus around a tooth at the gingival margin.
Time frame: Baseline
CAL is calculated by subtracting the gingival margin level from the probing depth.
Time frame: Baseline
Gingival recession is the apical migration of the gingival margin away from the cemento-enamel junction (CEJ), resulting in the exposure of the root surface of a tooth.
Abant Izzet Baysal University
Other
Investigation of the Effect of Periodontal Health on Smile Parameters: a Cross-Sectional
Acronym: EPHS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05127018
Behavior, Botulinum Toxins, Type A
Beijing, Beijing Municipality, China
View Trial DetailsNCT04527744
Behavior, Botulinum Toxins, Type A
Beijing, Beijing Municipality, China
View Trial DetailsNCT04820543
Behavior, Botulinum Toxins, Type A
Beijing, Beijing Municipality, China
View Trial DetailsNCT03812965
Behavior, Communication
São Paulo, Brazil
View Trial Details